Search Results

Reversine 5 mg  | 98.00%

TargetMol

Reversine, a small synthetic purine analogue (2, 6-disubstituted purine), is a potent inhibitior of Aurora A/B/C(IC50s=150-500 nM).

More Information Supplier Page

Reversine 50 mg  | 98.00%

TargetMol

Reversine, a small synthetic purine analogue (2, 6-disubstituted purine), is a potent inhibitior of Aurora A/B/C(IC50s=150-500 nM).

More Information Supplier Page

Reversine 25 mg  | 98.00%

TargetMol

Reversine, a small synthetic purine analogue (2, 6-disubstituted purine), is a potent inhibitior of Aurora A/B/C(IC50s=150-500 nM).

More Information Supplier Page

Reversine 100 mg  | 98.00%

TargetMol

Reversine, a small synthetic purine analogue (2, 6-disubstituted purine), is a potent inhibitior of Aurora A/B/C(IC50s=150-500 nM).

More Information Supplier Page

Carfilzomib 100 mg  | 99.60%

TargetMol

Carfilzomib is an irreversible proteasome inhibitor and antineoplastic agent that is used in treatment of refractory multiple myeloma.

More Information Supplier Page

Daclatasvir dihydrochloride 25 mg  | 99.84%

TargetMol

Daclatasvir is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and is used in combination with other oral antiviral agents to treat chronic hepatitis C. Elevations in serum enzyme levels during daclatasvir therapy are uncommon, and it has yet to be convincingly implicated in cases of clinically […]

More Information Supplier Page

Daclatasvir dihydrochloride 10 mg  | 99.84%

TargetMol

Daclatasvir is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and is used in combination with other oral antiviral agents to treat chronic hepatitis C. Elevations in serum enzyme levels during daclatasvir therapy are uncommon, and it has yet to be convincingly implicated in cases of clinically […]

More Information Supplier Page